Triglyceride-Glucose Index Association With Severity of Coronary Artery Disease

Sara Saffar Soflaei1, Pooria Salehi-Sangani2, Zahra Fallahi3

  • 1Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

The triglyceride-glucose (TyG) index is significantly associated with coronary artery disease (CAD). Higher TyG index values indicate a greater likelihood of developing multivessel CAD, particularly in diabetic individuals.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Biomarkers

Background:

  • The relationship between the triglyceride-glucose (TyG) index and coronary artery disease (CAD) requires further clarification.
  • Previous studies have yielded inconclusive results regarding this association.

Purpose of the Study:

  • To investigate the association between the TyG index and the presence and severity of CAD.
  • To determine if the TyG index can serve as a predictive marker for CAD.

Main Methods:

  • A study involving 2346 participants categorized by CAD status (no CAD, angiogram negative, single-vessel disease, two-vessel disease, three-vessel disease).
  • Calculation of the TyG index using fasting triglycerides and glucose levels: Ln [fasting TG (mg/dL) × fasting glucose (mg/dL)/2].
  • Analysis using adjusted regression models to assess the association between TyG index and CAD severity.

Main Results:

  • Elevated TyG index significantly correlated with increased odds of having three-vessel disease (3VD), two-vessel disease (2VD), and single-vessel disease (SVD).
  • Each unit increase in the TyG index was associated with higher odds of developing CAD across all severity levels compared to healthy participants.
  • The TyG index also showed a significant association with CAD severity when compared to the angiogram-negative group.

Conclusions:

  • The TyG index is significantly associated with the presence and severity of CAD.
  • Higher TyG index values are linked to an increased likelihood of multivessel CAD, especially in diabetic patients.
  • The TyG index may be a valuable biomarker for CAD risk assessment and patient stratification.
Abstract